1. Home
  2. ANAB vs BFC Comparison

ANAB vs BFC Comparison

Compare ANAB & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$54.57

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$156.22

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
BFC
Founded
2005
1894
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
ANAB
BFC
Price
$54.57
$156.22
Analyst Decision
Buy
Buy
Analyst Count
12
2
Target Price
$71.67
$157.00
AVG Volume (30 Days)
723.1K
78.7K
Earning Date
05-08-2026
04-16-2026
Dividend Yield
N/A
1.52%
EPS Growth
91.02
11.23
EPS
N/A
1.78
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
$58.67
Revenue Next Year
$52.14
$2.01
P/E Ratio
N/A
$87.69
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$115.29
52 Week High
$73.30
$156.99

Technical Indicators

Market Signals
Indicator
ANAB
BFC
Relative Strength Index (RSI) 47.10 65.48
Support Level $54.23 $139.17
Resistance Level $57.70 N/A
Average True Range (ATR) 3.31 4.69
MACD 0.04 0.70
Stochastic Oscillator 57.04 95.75

Price Performance

Historical Comparison
ANAB
BFC

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

Share on Social Networks: